Jpm (JPM) Shareholder Fulton Breakefield Broenniman LLC Increased Its Stake as Shares Rose

April 16, 2018 - By Anthony Rauscher

JPMorgan Chase & Co. (NYSE:JPM) Corporate LogoBig Money Sentiment decreased to 0.88 in Q4 2017. It has change of 0.03, from 2017Q3’s 0.91. The ratio dived due to JPM positioning: 55 sold and 802 reduced. 142 funds took holdings and 611 increased holdings. Investors holded 2.50 billion in 2017Q3 but now own 2.46 billion shares or 1.60% less. Macnealy Hoover Invest Incorporated holds 20,623 shs. Citigroup owns 2.90 million shs. Edgestream Prns Ltd Partnership holds 2,516 shs. Ferguson Wellman Capital Mgmt Inc holds 1.7% of its capital in JPMorgan Chase & Co. (NYSE:JPM) for 461,273 shs. Arrowstreet Cap Partnership invested in 0.01% or 35,200 shs. Everence Cap Mngmt reported 71,524 shs. Fiera Corporation owns 578,881 shs. Cubist Systematic Strategies has 0.27% invested in JPMorgan Chase & Co. (NYSE:JPM). Girard Ltd holds 1.42% or 69,326 shs. Zweig stated it has 0.06% of its capital in JPMorgan Chase & Co. (NYSE:JPM). Capwealth holds 51,760 shs. Apriem accumulated 64,753 shs. 117,630 are held by Guardian Advsr Ltd Partnership. Sadoff Mngmt Limited Liability Company stated it has 0.04% of its capital in JPMorgan Chase & Co. (NYSE:JPM). Osher Van De Voorde Invest Mgmt invested in 4.75% or 93,920 shs.

JPM had 9 selling transactions and 1 insider buy since October 25, 2017. This’s net activity of $22.34 million. On Saturday, January 13 $5.43 million worth of stock was sold by Petno Douglas B. 17,057 shs valued at $1.91M were sold by Scher Peter on Saturday, January 13. On Saturday, January 13 Friedman Stacey also sold $1.99 million worth of JPMorgan Chase & Co. (NYSE:JPM). On Saturday, January 13 $7.31 million worth of stock was sold by Erdoes Mary E.. Another trade for 9,194 shs valued at $1.03M was sold by Lake Marianne. On Saturday, January 13 the insider Giles Nicole sold $425,399.

Fulton Breakefield Broenniman Llc upped its holdings by 427.07% in Jpm (JPM), according to 2017Q4 SEC form. 82,041 shares were bought by Fulton Breakefield Broenniman Llc as the company’s stock rose 0.67% while stock markets declined. At the end of 2017Q4, the institutional investor held 101,251 shares of the major banks company, priced at $10.83M, up from 19,210 at the end of the previous reported quarter. Jpm has $378.08B MC. On during the last trading session the stock increased $0.5601 or 0.51%, reaching $110.8601.Currently JPMorgan Chase & Co. is uptrending after 23.99% change in last April 16, 2017. JPM has 1.00 million shares volume. JPM outperformed the S&P 500 by 12.44%.

Fulton Breakefield Broenniman Llc has cut its stake in and also reduced its holding in by shares in the quarter, for a total of shares.

JPMorgan Chase & Co. (NYSE:JPM) Ratings Coverage

Total analysts of 18 have positions in JP Morgan Chase (NYSE:JPM) as follows: 11 rated it a “Buy”, 0 with “Sell” and 7 with “Hold”. The positive are 61%. Since November 13, 2017 according to StockzIntelligence Inc JP Morgan Chase has 32 analyst reports. In Thursday, January 4 report Credit Suisse upgraded the stock to “Buy” rating. In Wednesday, February 21 report Morgan Stanley maintained it with “Overweight” rating and $136 target. On Wednesday, January 24 the rating was maintained by Credit Suisse with “Buy”. In Friday, April 13 report BMO Capital Markets maintained it with “Hold” rating and $11000 target. On Wednesday, February 28 the stock of JPMorgan Chase & Co. (NYSE:JPM) has “Neutral” rating given by Nomura. On Tuesday, January 2 the firm has “Buy” rating given by Barclays Capital. The stock rating was maintained by Sandler O’Neill with “Hold” on Tuesday, January 16. On Friday, January 12 the firm earned “Buy” rating by Bank of America. On Friday, February 2 the rating was maintained by Morgan Stanley with “Overweight”. The stock rating was maintained by RBC Capital Markets with “Buy” on Monday, November 13.

JPMorgan Chase & Co. (NYSE:JPM) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.